Opinion|Videos|August 19, 2024
Patient Access Advocacy for BTK Inhibitors
A panel of specialists discuss patient access advocacy for BTK inhibitors.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- How do changes in patient out-of-pocket costs under the IRA influence treatment and sequencing decisions?
- What strategies can healthcare providers use to advocate for patient access to BTK inhibitors?
Advertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves First Oral Carbapenem Antibiotic for Complicated UTIs
2
Oral COVID-19 PEP May Benefit High-Risk Groups More Than General Public: Peter J. Hotez, MD
3
Walcker Named President of Cardinal’s The Specialty Alliance, With Strengths in GI, Urology
4
Fourteen Years of HIV PrEP: How New Innovations Build on Decades of Progress in HIV
5